Comparative study of efficacy between Topical Capsaicin 0.025% w/w, Capsaicin 0.075% w/w, and Oral Pregabalin in Diabetic Peripheral Neuropathy- A Randomized Controlled Clinical Trial. - CAPRE

Dr Faizuddin Ahmed0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1) Subjects who are consenting to participate in the study.
•2) Subjects must be ambulatory.
•3) Subjects should experience at least one symptom of Diabetic Neuropathy in their peripheries like tingling, numbness, burning, and pricking sensation in the limbs.

•1) Subjects who arenâ??t consenting to participate in the study.
•2) Subjects below 18 years of age and above 70 years.
•3) Subjects with certain comorbid conditions which can trigger neuropathy like, CKD, HIV/AIDS, Vasculitis, Amyloid Polyneuropathy, Sarcoidosis, Guillain-Barre Syndrome, Women with hot flushes (Menopausal period), Postherpetic Neuralgia, Heavy Metal Poisoning, Skin rashes, Erythema, Psoriasis, Scleroderma, Steven- Johnsonâ??s Syndrome, Toxic Epidermal Necrolysis.
•4) Subjects with physically debilitating conditions like Rheumatoid Arthritis, Osteoarthritis and other bone and joint disorders. Subjects suffering from physical trauma due to accidents.
•5) Subjects who are takin neuropathy-triggering medications like Amiodarone, Cancer chemotherapeutic agents like Platinum based compounds, Paclitaxel, Anti-malarials like Chloroquine, Dapsone, other drugs like Isoniazid, Nitrofurantoin, Carbamazepine, Phenytoin, and Phenobarbital.

发起方

Dr Faizuddin Ahmed